Patents

Lack of enablement in Amgen v Sanofi and Regeneron

Amgen v Sanofi and Regeneron: Broad antibody patents held invalid for lack of enablement in US Lack of enablement: A conclusion of lack of enablement means that the disclosure provided in the patent specification, at the time the application was filed, would not have taught one skilled in the art how to make and/or use the full… Read more »

Partner Mike Jennings is reappointed to SACEPO

We are delighted that Partner Mike Jennings has been appointed by the EPO President to continue his contributions to the SACEPO Working Party on Quality for another 3 years. What is SACEPO? The Standing Advisory Committee before the European Patent Office (SACEPO) was formed in 1978. Its aim was to give “interested circles” a say… Read more »

Patenting in the Pandemic

Partner Dr. Lawrence King reflects on Patenting in the Pandemic and the importance of locking down innovation in troubled times in this article, first published in The Chemical Engineer. The importance of locking down innovation in troubled times TO MOST, A Poor Man’s Tale of a Patent, published in October 1850, remains one of Charles Dickens’ lesser-known… Read more »

UKIPO “Green Channel” – can the patent system encourage more innovation in green technologies?

Partners Mike Jennings and Alex Bone explore the UKIPO “Green Channel” At AA Thornton, our patent attorneys have a long history of assisting innovators seeking protection for a variety of green technology including solar technology, waste processing and wind turbines.  Some of our clients were kind enough to share their stories with us, and you… Read more »

AI and IP – A report on CIPA’s Computer Technology Committee recommendations on AI and IP

Whether and when to change UK patent law to increase protection for AI This article follows the recent article ‘Call for industry views on AI and IP and ViCo‘   Introduction In September 2020, the UKIPO launched a “Call for views on AI and IP” (see https://www.gov.uk/government/consultations/artificial-intelligence-and-intellectual-property-call-for-views ), noting the UK government’s desire to understand… Read more »

Call for industry views on AI and IP and ViCo

AA Thornton’s Mike Jennings joins the EPO, UKIPO and USPTO in inviting industry comments on the recent IP office consultations   The era of public consultations In the last 3 years, several intellectual property offices have invited the global IP community to express our views on what we need from them and from legislators. The… Read more »

Access to Intellectual Property (IP) Rights in a Time of Emergency – Patent Pools and Beyond

Access to Intellectual Property (IP) Rights in a Time of Emergency – Patent Pools and Beyond This article was first published in BioScience Today The pharmaceutical and healthcare industry is often accused of misusing IP to extend exclusivity and delay reasonably priced access to life saving technologies. The recent pandemic has focussed attention on the… Read more »

Artificial Intelligence: Patentability and Inventorship in Europe

Artificial Intelligence: Patentability and Inventorship in Europe AA Thornton and the EPO’s Director of Patent Law explained the EPO’s approach to AI patenting, in discussion with the IP Institute of Canada.   The UK Chartered Institute of Patent Attorneys (CIPA) and the IP Institute of Canada (IPIC) invited the European Patent Office Director of Patent… Read more »

Categories

Archives